Drug developer ChanRx has closed a series A round of investment that it will use to fund clinical trials of a pharmaceutical to treat atrial fibrillation. The Cleveland-area company, which was spun off from pharmaceutical testing firm ChanTest in 2006, didn’t specify the amount of the investment in a prepared statement. The round was led […]
Pharmaceutical testing company ChanTest has achieved several “firsts” in its 13 years, most related to the company’s drug discovery work with electricity-producing proteins called ion channels. Add another: The Cleveland-area company has been chosen as the first recipient of MedCity Media’s “The Cities” Healthcare Ally award, given to a service provider that has demonstrated extraordinary service […]
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Updated 2:47 p.m., Aug. 5, 2010. Two-year-old drug development company ChanRx has received a $250,000 investment commitment from JumpStart Ventures, the investment arm of Northeast Ohio venture developer JumpStart Inc. ChanRx was spun off by ChanTest Corp. in Garfield Heights, Ohio, to develop small-molecule drugs — specifically, Vanoxerine — to treat atrial fibrillation, an increasingly […]
Kendle International, the clinical research organization in Cincinnati, has received approval from Indian authorities to open an operations center in a Special Economic Zone in the Ahmedabad-Gandhinagar Knowledge Corridor by mid-April.
A $10 million public-private deal with Cardinal Health and Ohio State was the largest of several Third Frontier grants for biomedical companies or organizations announced Wednesday. Altogether, imaging companies and organizations received $20 million in funding. Out of eight total grant announcement, Cleveland-area companies were involved in five.
Dr. Arthur "Buzz" Brown describes his company's acquisition of a Rockville, Md., contract research organization as a 1-plus-1-equals-5 kind of deal. Last week, ChanTest acquired Applied Cell Sciences in Rockville, Md., for undisclosed terms.
